Vol 14, No 3 (June 30, 2026): Annals of Translational Medicine

Original Article | Clinical Studies

Does lung adenocarcinoma subtyping offer clinical benefits?—a retrospective population-based cohort study from Sweden
Frantisek Zitricky, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli Hemminki, Rudolf Kaaks, Kari Hemminki
Annals of Translational Medicine  
2026;
14
(3)
:31
.
Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network
Omar Abdelhalim, Mohammed Y. Youssef, Sawsan Al-Lababidi, Mohamed H. Eldesouki, Ahmed Mohamed, Mohammed Abusuliman, Mahmoud Nassar, Mohammad Abushanab, Ahmed Salem, Hassan Shaheen, Ahmed Aref, Khaled M. Elhusseiny, Chloe Lahoud, Zara Bhutta, Hazem Abosheaishaa
Annals of Translational Medicine  
2026;
14
(3)
:32
.

Brief Report | Emerging Medical Technology Innovation and Translation

Tutorial: translating a validated breast cancer prediction model into a web-based decision aid using R Shiny
Emily A. Wolfson, Long H. Ngo, Mara A. Schonberg
Annals of Translational Medicine  
2026;
14
(3)
:33
.

Review Article | Biomarkers Sciences

Clonal hematopoiesis of indeterminate potential (CHIP)—a pivotal contributor of aging and related disorders
Ankita Dhenge, Rohan Kulkarni
Annals of Translational Medicine  
2026;
14
(3)
:34
.

Review Article | Emerging Medical Technology Innovation and Translation

Light therapy in medicine: where do we stand?
Yoshimasa Oyama, Andrea Witowski, Michael Adamzik, Karsten Bartels, Tobias de la Garza Eckle
Annals of Translational Medicine  
2026;
14
(3)
:35
.

Review Article | Data Sciences

Beyond the algorithm: health technology assessment frameworks for AI in cardiology under the European Union Health Technology Assessment Regulation: a systematic review
Lucía Osoro, Baptiste Vasey, Peter McCulloch, Felix Broghammer, Stephen Gilbert, Juan Carlos Rejon-Parrilla, Dipak Kalra, Rubén Casado-Arroyo
Annals of Translational Medicine  
2026;
14
(3)
:36
.

Review Article | Data-Driven Clinical Practice and Policy Making

Chronic eczematous eruptions of aging: a clinical practice review
J. Skylar Westerdahl, Richard D. Sontheimer
Annals of Translational Medicine  
2026;
14
(3)
:37
.

Case Report | Clinical Studies

Bronchoscopic photodynamic therapy for endobronchial metastatic papillary thyroid carcinoma causing lobar airway obstruction: a case report
Amir R. Reihani, Bhavana Konda, Fadi A. Nabhan, Peter Kobalka, Alberto E. Revelo
Annals of Translational Medicine  
2026;
14
(3)
:38
.

Editorial Commentary | Clinical Studies

Effect of combining peripheral defocus spectacle lens wear with 0.01% atropine
Sayantan Biswas, James S. Wolffsohn
Annals of Translational Medicine  
2026;
14
(3)
:39
.

Editorial Commentary | Emerging Therapeutics

Menin inhibition reshapes therapy in NPM1-mutated acute myeloid leukemia
Thura Win Htut, Musa Yilmaz
Annals of Translational Medicine  
2026;
14
(3)
:40
.

Editorial Commentary | Data Sciences

Limitations of large language model-generated multiple-choice questions in ophthalmology
Vincent Xiao, Zachary Elkin, Christina Prescott, Jung G. Kim, Kiran Malhotra
Annals of Translational Medicine  
2026;
14
(3)
:41
.

Editorial Commentary | Biomarkers Sciences

Circulating tumor DNA (ctDNA)-guided adjuvant therapy for muscle-invasive bladder cancer (MIBC): ready for primetime?
Eric W. Martin, Jeanny B. Aragon-Ching
Annals of Translational Medicine  
2026;
14
(3)
:42
.

Editorial Commentary | Clinical Studies

Efficacy and safety of different atropine regimens: MOSAIC2
Audrey Chia
Annals of Translational Medicine  
2026;
14
(3)
:43
.

Letter to the Editor | Clinical Studies

Response to commentary: “Propofol-based total intravenous anesthesia and recurrence-free survival after hepatectomy-does it improve outcomes?”
Ji-Hye Kwon, Jeayoun Kim, Gaab Soo Kim
Annals of Translational Medicine  
2026;
14
(3)
:44
.